Free shipping on all orders over $ 500


Cat. No. M6249
BMS-813160  Structure
Size Price Availability Quantity
5mg USD 320 In stock
10mg USD 500 In stock
50mg USD 1500 In stock
Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity > 99%
  • COA
  • MSDS
Biological Activity

BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 484.64
Formula C25H40N8O2
CAS Number 1286279-29-5
Purity > 99%
Solubility 25 mg/mL in DMSO
Storage at -20°C

A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916.
Norman P, et al. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24. PMID: 21936726.

Related Products

Fadrozole is a potent, selective and nonsteroidal inhibitor of aromatase with an IC50 of 6.4 nM.

PKM2 inhibitor

PKM2 inhibitor displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.


CA-4948 is a reversible kinase inhibitor that modulates IRAK4 function in both the toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) signaling cascades, and demonstrates pharmacodynamic and antitumor activity in in vitro and in vivo nonclinical models.


ONC212, a fluorinated-ONC201 analogue, is broadly efficacious across most solid tumors and hematological malignancies in the low nanomolar range and has robust anti-leukemic activity.


JPH203, a selective L-type amino acid transporter 1 inhibitor, shows a dramatic inhibition of leucine uptake (IC50=0.06 µM) and cell growth (IC50=4.1 µM) in human colon cancer cells (HT-29), human oral cancer cells (YD-38) and leukemic cells.

Abmole Inhibitor Catalog 2017

Keywords: BMS-813160 supplier, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.